Tamara A

Health innovations ⚕️

[Tamara A @TAlagirova]

@ProfSNicholls @MonashUni @MonashHealth @sahmriAU @ClevelandClinic Congratulations!!!

[Tamara A @TAlagirova]

@MonashVHI @ProfSNicholls @MonashUni @MonashHealth @SCSMonash Congratulations!!!

[Tamara A @TAlagirova]

Are you attending the AHA in Philadelphia this week & want to meet❓Moncyte technology provides a unique view at biological processes underlying disease progression and drug action, and thereby offers new ways to look at residual risk for recipients of lipid-lowering medication.

[Tamara A @TAlagirova]

@pedroamst Hola Pedro, comp estas?? Cuanto tiempo

[Tamara A @TAlagirova]

Thank you for the invitation Novartis and PMNET Forum! It was a great opportunity to talk about precision medicine in cardiovascular health and how https://t.co/KkstqK3og9 technology can help. Great meeting in beautiful Riga, Latvia! @HelsinkiUniMed @Novartis @SimonPfisterer

[Tamara A @TAlagirova]

@CBallantyneMD I can see a sign saying “dance program”

[Tamara A @TAlagirova]

@CBallantyneMD @CMHC_CME @PamTaubMD @ErinMichos Wow! I wish I could have attended this Zumba class!

[Tamara A @TAlagirova]

@CBallantyneMD @kdrosato @Lpa_Doc @gbakris Congratulations! What an achievement.

[Tamara A @TAlagirova]

@ProfKausikRay Definitely sharing the same passion🌿

[Tamara A @TAlagirova]

Summer holidays are for enjoying the sun, dancing and gardening ☀️💚

[Tamara A @TAlagirova]

@elinapimia @DrPietilainen Hyvä Kirsi!

[Tamara A @TAlagirova]

@ProfKausikRay Congratulations! 👏👏👏

[Tamara A @TAlagirova]

Novel functional test linking different cellular profiles to the outcomes of cholesterol-lowering therapy in the general population.💥 Value: new data for optimal treatment recommendation, identify patients needing more effective therapy.

https://t.co/MWCkogEHBf
@ry_saty

[Tamara A @TAlagirova]

@elinapimia @tomibjorck Voi ei 😅

[Tamara A @TAlagirova]

Attending Finnish Atherosclerosis Society meeting at Porvoo. Keynote speaker by Chris Packard from Glasgow University, UK. ☀️ Next week: German Atherosclerosis Society meeting and EAS. Looking forward to meeting you there @ProfKausikRay.

[Tamara A @TAlagirova]

@EpiHeartOy @MHH_life Congratulations Kai and the EpiHeart team!

[Tamara A @TAlagirova]

Exciting results from our biobank study out as a preprint!💥 Moncyte test can generate new type of data on cellular processes that, for the first time, enables us to understand individual variations & provide an optimal treatment recommendation and cardiovascular risk assessment.

[Simon Pfisterer @SimonPfisterer]

New manuscript out as preprint! We performed in-depth functional profiling of 400 individuals to elucidate how biological variation in cellular processes link to treatment outcomes of cholesterol-lowering medication. @HelsinkiUniMed @helsinkiuni @samrip https://t.co/gdR1VX7GqP

[Health Capital Helsinki @HealthHelsinki]

Four out of top 8 #healthtech #startups at #EHIF23 are from Helsinki Metropolitan - congratulations @GlucoModicum @KoiteHealth Moncyte and @NADMED_Ltd! 🌟

👆 Keep an eye on these companies – future of health is made in Finland 🇫🇮

@TechTourHQ @BusinessFinland

[Tamara A @TAlagirova]

And the best presenting company award from 200+ applicants goes to… Moncyte! 💥💥💥

Thank you to all investors for your vote of confidence at the European Healthtech Investment Forum, a go-to-event for any Life Science company.

@HelsinkiUniMed @LabPfisterer @BusinessFinland

[Tamara A @TAlagirova]

Great two days of networking and presenting Moncyte along with my amazing startup colleagues at the European Healthtech Investment Forum!

Thank you for the organizers from @BusinessFinland Finland and Tech Tour for a great Life Science event! 🌟

@LabPfisterer @HelsinkiUniMed